Evidence map›Paper›PMID 41464866›Full record

ReviewJournal of clinical medicine2025

The Vagal Link: Autonomic Nervous System Dysfunction in Cardiac Amyloidosis.

Federico Barocelli, Eleonora Canu, Nicolò Pasini, Isabella Allegri, Alessandro D'Orsi, Alberto Bettella, Antonio Crocamo, Filippo Luca Gurgoglione, Laura Torlai Triglia, Francesca Russo and 5 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Federico BarocelliCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0000-0002-1412-4747
Eleonora CanuCardiology Division, Parma University Hospital, 43126 Parma, Italy.
Nicolò PasiniCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0009-0007-2895-4219
Isabella AllegriNeurology Division, Parma University Hospital, 43126 Parma, Italy.
Alessandro D'OrsiNeurology Division, Parma University Hospital, 43126 Parma, Italy.
Alberto BettellaCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0009-0001-0081-4720
Antonio CrocamoCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0009-0003-8290-5478
Filippo Luca GurgoglioneCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0000-0001-7539-5463
Laura Torlai TrigliaCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0000-0002-0645-8974
Francesca RussoCardiology Division, Parma University Hospital, 43126 Parma, Italy.
Angela GuidorossiCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0009-0005-7450-9365
Maria Francesca NotarangeloCardiology Division, Parma University Hospital, 43126 Parma, Italy.
Nicola GaibazziCardiology Division, Parma University Hospital, 43126 Parma, Italy.
Livia RuffiniNuclear Medicine Unit, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0002-4398-8368
Giampaolo NiccoliCardiology Division, Parma University Hospital, 43126 Parma, Italy.ORCID 0000-0002-3187-6262

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac amyloidosis (CA) is an increasingly recognized cause of restrictive cardiomyopathy in which extracellular amyloid deposition leads to progressive structural and functional impairment. Beyond myocardial infiltration, growing evidence highlights the central role of autonomic nervous system dysfunction (ANS) -particularly the vagal nerve involvement-as a contributor to orthostatic intolerance, syncope, exercise limitation, arrhythmias, and reduced quality of life. Emerging data suggest that autonomic impairment may precede overt cardiac manifestations, offering a potential window for earlier recognition. This narrative review summarizes current knowledge on the mechanisms and clinical relevance of autonomic dysfunction in CA, emphasizing the novelty of the "vagal link" as a unifying framework connecting with a specific focus on the vagus nerve (VN) and its complex interplay with cardiac structure and function. We further discuss diagnostic approaches and the potential role of autonomic assessment in early detection, risk stratification, and personalized treatment strategies. A clearer understanding of vagal dysfunction may provide new insights into disease progression and identify opportunities for therapeutic innovation.

Indexed as

amyloid neuropathyautonomic dysfunctionautonomic nervous systemcardiac amyloidosisheart-brain axisorthostatic hypotensiontransthyretin amyloidosisvagus nerve

Identifiers

PMID41464866
PMCPMC12733568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.